Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Issue Archive

Table of Contents

BLOOD COMMENTARIES

CLINICAL TRIALS AND OBSERVATIONS
Hematopoiesis and Stem Cells
MYELOID NEOPLASIA

PLENARY PAPER

CLINICAL TRIALS AND OBSERVATIONS
Katja M. J. Heitink-Pollé,for the TIKI Investigators,Cuno S. P. M. Uiterwaal,for the TIKI Investigators,Leendert Porcelijn,for the TIKI Investigators,Rienk Y. J. Tamminga,for the TIKI Investigators,Frans J. Smiers,for the TIKI Investigators,Nicole L. van Woerden,for the TIKI Investigators,Judit Wesseling,for the TIKI Investigators,Gestur Vidarsson,for the TIKI Investigators,Annemieke G. Laarhoven,for the TIKI Investigators,Masja de Haas,for the TIKI Investigators,Marrie C. A. Bruin,for the TIKI Investigators

SPECIAL REPORT

Peter Dreger,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Paolo Ghia,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Johannes Schetelig,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Michel van Gelder,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Eva Kimby,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Mauricette Michallet,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Carol Moreno,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Tadeusz Robak,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Stephan Stilgenbauer,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Emili Montserrat,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT)

REVIEW ARTICLE

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY AND IMMUNOTHERAPY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

THROMBOSIS AND HEMOSTASIS

LETTER TO BLOOD

BLOOD WORK

ERRATUM

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals